HLA DR (Activation Marker)

Yes. HLA-DR is an MHC class II molecule whose surface expression increases with immune activation and is commonly used as an activation marker on antigen-presenting cells (monocytes, dendritic cells) and activated T cells. Clinically, reduced monocyte HLA-DR indicates immune suppression (eg, in sepsis), while upregulation reflects antigen presentation and immune activation.

HLA-DR is an MHC class II cell-surface protein that marks antigen-presenting cells (dendritic cells, B cells, macrophages/monocytes) and indicates immune activation. Clinically, monocyte HLA-DR levels reflect immune competence—often decreased in severe infection or immunosuppression and elevated in autoimmune or inflammatory conditions—so it’s used to assess immune status and guide management in critical illness and immune disorders.

HLA-DR is an MHC class II surface protein expressed on antigen-presenting cells — including myeloid-lineage cells (monocytes, macrophages, dendritic cells) and B lymphocytes. In clinical flow cytometry it's commonly used as a myeloid/monocytic marker, but it is not exclusively myeloid. Presence or absence helps classify leukemias and assess immune activation or dysfunction (e.g., monocyte HLA-DR downregulation in sepsis).

HLA‑DR is constitutively expressed on professional antigen‑presenting cells: dendritic cells, macrophages (including microglia), monocytes and B lymphocytes. Activated CD4+ and CD8+ T cells can also upregulate HLA‑DR. Under inflammatory signals (e.g., interferon‑γ), other cell types such as endothelial and some epithelial cells, and occasionally tumor cells in inflamed tissues, may be induced to express HLA‑DR.

HLA-DR is one type of human MHC class II molecule. MHC class II refers broadly to proteins (including HLA-DR, HLA-DQ, HLA-DP) that present extracellular peptide antigens to CD4+ T cells. So HLA-DR is not the entire MHC II family but a major subgroup of human MHC class II molecules, mainly on antigen-presenting cells.

The HLA-DR gene encodes an MHC class II molecule expressed on antigen-presenting cells (dendritic cells, macrophages, B cells). It binds and presents extracellular peptide fragments to CD4+ helper T cells, initiating and regulating adaptive immune responses. HLA-DR also influences immune recognition, vaccine responses, transplant compatibility, and genetic susceptibility to certain autoimmune diseases.